Respiratory Virus Data Channel Weekly Snapshot
Provides a summary of the key viral respiratory illness findings for COVID-19, influenza, and RSV from the past week and access to additional information and figures.
Note: data summaries are based on CDC subject matter expert interpretation of publicly available findings across multiple data systems, some of which are not included in the data visualizations on these web pages.
Seasonal influenza, COVID-19, and RSV activity continues to decrease in most areas of the country. Hospital bed occupancy for all patients, including within ICUs, remains stable nationally.
Influenza
Nationally, seasonal influenza activity continues to decrease. Additional information about current influenza activity can be found at: Weekly U.S. Influenza Surveillance Report | CDC.
COVID-19
Most key indicators, including wastewater viral activity, are showing low levels of activity nationally.
RSV
All ten regions of the country are below the 3% percent positivity epidemic threshold indicating that the RSV season is ending. Hospitalization rates are low in all age groups.
Vaccination
National vaccination coverage for COVID-19, influenza, and RSV vaccines remained low for children and adults for the 2023-24 respiratory illness season. COVID-19 vaccines continue to be recommended and can provide a layer of protection.
Discover data stories
Provides an update on how COVID-19, influenza, and RSV may be spreading nationally and in your state.
Provides an update on how respiratory viruses are contributing to serious health outcomes, like hospitalizations and deaths, both nationally and in your state.
Provides an update on how COVID-19, influenza, and RSV illness, hospitalizations, and deaths are affecting different groups.
Provides an update on current overall hospital occupancy levels and how patients hospitalized with COVID-19 or influenza are contributing to inpatient and intensive care unit bed use.
Provides an update on receipt of vaccination and intent for vaccination for COVID-19 (children and adults), influenza (children and adults), and RSV (adults) based on weekly updated National Immunization Survey (NIS) survey responses.